• Molecular NameHalazepam
  • SynonymHalazepamum [INN-Latin]
  • Weight352.743
  • Drugbank_IDDB00801
  • ACS_NO23092-17-3
  • Show 3D model
  • LogP (experiment)3.97
  • LogP (predicted, AB/LogP v2.0)3.68
  • pkaN/A
  • LogD (pH=7, predicted)3.68
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.82
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds3
  • TPSA32.67
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA benzodiazepine derivative and is marketed under the brand names Alapryl and Pacinone. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half lifeN/A
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A